Avantor and Catalent Ink Multi-year Supply and Services Deal
Provider will be CDMO’s primary material supplier in the lab, clinical, and production settings
Avantor, a provider products and services to customers in the life sciences industry, has entered into a multi-year supply and services agreement with Catalent, a contract development and manufacturing organization (CDMO).
Per the terms of the agreement, Avantor will be the main supplier of a various types of laboratory supplies, clinical and production materials, and services to Catalent, which is an expansion on the parties’ existing relationship.
"Catalent has built tremendous global capabilities and a reputation as a trusted collaborator to pharma, biotech and consumer health partners throughout the development and production lifecycle," says Michael Stubblefield, president and CEO of Avantor. "We are pleased to expand our support for Catalent and enable efficiencies to accelerate science for their customers around the globe."
Read more about the companies’ multi-year agreement here.
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
